Abstract
Abstract About 10% of cancer cells employ the “alternative lengthening of telomeres” (ALT) pathway instead of re‐activating the hTERT subunit of human telomerase. The hTR RNA subunit is also abnorm...
Cite
CITATION STYLE
APA
Raghunandan, M., Geelen, D., Majerova, E., & Decottignies, A. (2021). NHP2 downregulation counteracts hTR‐mediated activation of the DNA damage response at ALT telomeres. The EMBO Journal, 40(6). https://doi.org/10.15252/embj.2020106336
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free